Journal of Molecular and Cellular Cardiology
Volume 43, Issue 2 , Pages 159-167 , August 2007

Cardiac repolarization is prolonged in CD4C/HIV transgenic mice

  • Judith Brouillette

      Affiliations

    • Research Center, Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec, Canada H1T 1C8
    • Faculty of Pharmacy, University of Montreal, Canada
    • These two authors contributed equally to this study.
    • ,
  • Scott A. Grandy

      Affiliations

    • Research Center, Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec, Canada H1T 1C8
    • Faculty of Pharmacy, University of Montreal, Canada
    • These two authors contributed equally to this study.
    • ,
  • Paul Jolicoeur

      Affiliations

    • Clinical Research Institute of Montreal, Canada
    • ,
  • Céline Fiset

      Affiliations

    • Research Center, Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec, Canada H1T 1C8
    • Faculty of Pharmacy, University of Montreal, Canada
    • Corresponding Author InformationCorresponding author. Research Center, Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec, Canada H1T 1C8. Tel.: +1 514 376 3330x3025; fax: +1 514 376 1355.

Received 20 February 2007 ,Revised 3 May 2007 ,Accepted 10 May 2007.

References 

  1. Herskowitz A. Cardiomyopathy and other symptomatic heart diseases associated with HIV infection. Curr. Opin. Cardiol. 1996;11:325–331
  2. Lipshultz SE, Chanock S, Sanders SP, Colan SD, Perez-Atayde A, Mcintosh K. Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am. J. Cardiol. 1989;63:1489–1497
  3. Reilly JF, Cunnion RE, Anderson DW, O'Leary T, Simmons JT, Lane HC, et al. Frequency of myocarditis, left ventricular dysfunction and ventricular tachycardia in the acquired immune deficiency syndrome. Am. J. Cardiol. 1988;62:789–793
  4. Cohen AJ, Weiser B, Afzal Q, Fuhrer J. Ventricular tachycardia in two patients with AIDS receiving ganciclovir (DHPG). AIDS. 1990;4:807–809
  5. Eisenhauer M, Eliasson AH, Taylor AJ, Coyne PE, Wortham DC. Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients. Chest. 1994;105:389–395
  6. Sani MU, Okeahialam BN. QTc interval prolongation in patients with HIV and AIDS. J. Natl. Med. Assoc. 2005;97:1657–1661
  7. Kocheril AG, Bokhari SA, Batsford WP, Sinusas AJ. Long QTc and torsades de pointes in human immunodeficiency virus disease. Pacing Clin. Electrophysiol. 1997;20:2810–2816
  8. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998;98:2334–2351
  9. Vallejo CN, Rodriguez PD, Sanchez HA, Tornos Mas MP, Ribera E, Soler SJ. Ventricular tachycardia and long QT associated with clarithromycin administration in a patient with HIV infection. Rev. Esp. Cardiol. 2002;55:878–881
  10. Sani MU, Okeahialam BN, Aliyu SH, Enoch DA. Human immunodeficiency virus (HIV) related heart disease: a review. Wien. Klin. Wochenschr. 2005;117:73–81
  11. Anson BD, Weaver JG, Ackerman MJ, Akinsete O, Henry K, January CT, et al. Blockade of HERG channels by HIV protease inhibitors. Lancet. 2005;365:682–686
  12. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P. Nef harbors a major determinant of pathogenicity for AIDS-like disease by HIV-1 in transgenic mice. Cell. 1998;95:163–175
  13. Hanna Z, Kay DG, Cool M, Jothy S, Rebai N, Jolicoeur P. Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J. Virol. 1998;72:121–132
  14. Facker OT, Baur AS. Live or let die: Nef functions beyond HIV replication. Immunity. 2002;16:493–497
  15. Brouillette J, Yue P, Fiset C, Jolicoeur P. Delayed cardiac repolarization in HIV transgenic mice. Circulation. 2001;104:II–133
  16. Brouillette J, Yue P, Jolicoeur P, Fiset C. The gene nef is responsible for the lengthening of cardiac repolarization in HIV mice. Circulation. 2003;108:IV-119
  17. Trépanier-Boulay V, St-Michel C, Tremblay A, Fiset C. Gender-based differences in cardiac repolarization in mouse ventricle. Circ. Res. 2001;89:437–444
  18. Mitchell GF, Jeron A, Koren G. Measurement of heart rate and QT interval in the conscious mouse. Am. J. Physiol. 1998;274:H747–H751
  19. Gehrmann J, Berul CI. Cardiac electrophysiology in genetically engineered mice. J. Cardiovasc. Electrophysiol. 2000;11:354–368
  20. Berul CI, McConnell BK, Wakimoto H, Moskowitz IP, Maguire CT, Semsarian C, et al. Ventricular arrhythmia vulnerability in cardiomyopathic mice with homozygous mutant myosin-binding protein C gene. Circulation. 2001;104:2734–2739
  21. Fiset C, Clark RB, Larsen TS, Giles WR. A rapidly activating sustained K+ current modulates repolarization and excitation–contraction coupling in adult mouse ventricle. J. Physiol. 1997;504:557–563
  22. Brouillette J, Clark RB, Giles WR, Fiset C. Functional properties of K+ currents in adult mouse ventricular myocytes. J. Physiol. 2004;559:777–798
  23. Beuckelmann DJ, Nabauer M, Erdmann E. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ. Res. 1993;73:379–385
  24. Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, et al. Ionic mechanisms of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ. Res. 1996;78:262–273
  25. Nerbonne JM, Kass RS. Molecular physiology of cardiac repolarization. Physiol. Rev. 2005;85:1205–1253
  26. Twagirumukiza M, Nkeramihigo E, Seminega B, Gasakure E, Boccara F, Barbaro G. Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda. Curr. HIV Res. 2007;5:129–137
  27. Fisher SD, Lipshultz SE. Epidemiology of cardiovascular involvement in HIV disease and AIDS. Ann. N. Y. Acad. Sci. 2001;946:13–22
  28. Keesler MJ, Fisher SD, Lipshultz SE. Cardiac manifestations of HIV infection in infants and children. Ann. N. Y. Acad. Sci. 2001;946:169–178
  29. Topilski I, Rogowski O, Rosso R, Justo D, Copperman Y, Glikson M, et al. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. J. Am. Coll. Cardiol. 2007;49:320–328
  30. Heckmann A, Waltzinger C, Jolicoeur P, Dreano M, Kosco-Vilbois MH, Sagot Y. IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS. Am. J. Pathol. 2004;164:1253–1262
  31. Wang J, Wang H, Zhang Y, Gao H, Nattel S, Wang Z. Impairment of HERG K(+) channel function by tumor necrosis factor-alpha: role of reactive oxygen species as a mediator. J. Biol. Chem. 2004;279:13289–13292
  32. Petkova-Kirova PS, Gursoy E, Mehdi H, McTiernan CF, London B, Salama G. Electrical remodeling of cardiac myocytes from mice with heart failure due to the over-expression of tumor necrosis factor {alpha}. Am. J. Physiol.: Heart Circ. Physiol. 2005;290:H2098–H2107
  33. Vallejo CN, Rodriguez PD, Sanchez HA, Tornos Mas MP, Ribera E, Soler SJ. Ventricular tachycardia and long QT associated with clarithromycin administration in a patient with HIV infection. Rev. Esp. Cardiol. 2002;55:878–881
  34. Kikuchi Y, Genka I, Ishizaki A, Sunagawa K, Yasuoka A, Oka S. Serious bradyarrhythmia that was possibly induced by lopinavir-ritonavir in 2 patients with acquired immunodeficiency syndrome. Clin. Infect. Dis. 2002;35:488–490
  35. London B. Cardiac arrhythmias: from (transgenic) mice to men. J. Cardiovasc. Electrophysiol. 2001;12:1089–1091
  36. Salama G, London B. Mouse models of long QT syndrome. J. Physiol. 2007;578:43–53

PII: S0022-2828(07)01046-2

doi: 10.1016/j.yjmcc.2007.05.007

Journal of Molecular and Cellular Cardiology
Volume 43, Issue 2 , Pages 159-167 , August 2007

Article Tools

* Image Usage & Resolution